Brief: Codiak Reports Positive Initial Phase 1 Results For exoIL-12 In Healthy Volunteers

Codiak BioSciences,.

30/12/2020 12:37

Dec 30 (Reuters) - Codiak BioSciences Inc  CDAK.O :
    * CODIAK REPORTS POSITIVE INITIAL PHASE 1 RESULTS FOR
EXOIL-12™
DEMONSTRATING TOLERABILITY AND ABSENCE OF SYSTEMIC IL-12
EXPOSURE IN HEALTHY VOLUNTEERS
    * CODIAK BIOSCIENCES, INC. - PRIMARY OBJECTIVES WERE MET IN
INITIAL PART OF ITS PHASE 1 TRIAL
    * CODIAK BIOSCIENCES, INC. - EXOIL-12 RESULTED IN NO LOCAL
OR
SYSTEMIC TREATMENT-RELATED ADVERSE EVENTS
    * CODIAK BIOSCIENCES, INC. - LOCAL ADMINISTRATION OF
EXOIL-12
DEMONSTRATED NO SYSTEMIC EXPOSURE TO IL-12
    * CODIAK BIOSCIENCES, INC. - DOSE SELECTION DATA AND
ADVANCEMENT
INTO MULTI-DOSE STUDY IN CUTANEOUS T CELL LYMPHOMA PATIENTS
ANTICIPATED IN Q1 2021

Source text for Eikon:  ID:nGNX7vZjwm 
Further company coverage:  CDAK.O 

 ((Reuters.Briefs@thomsonreuters.com;))